Jae-Kyo Kim
Fortuna: 807 196 $ al 30/06/2026
Fortuna: 807 196 $ al 30/06/2026
Jae-Kyo Kim currently works at Hanmi Science Co., Ltd., as Vice Chairman & Chief Executive Officer from 2025.
Mr. Kim also formerly worked at Yuhan Corp., as Director & Head-Global Strategy.
Mr. Kim received his undergraduate degree from Kyungpook National University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
Immuneoncia Therapeutics, Inc.
Immuneoncia Therapeutics, Inc. BiotechnologyHealth Technology Provides drug development and antibody engineering services for oncology patients 0,3 % | 30/04/2025 | 269.370 ( 0,3 % ) | 622 439 $ | 30/06/2026 |
HANMI SCIENCE CO., LTD 0,01 % | 02/07/2026 | 9.494 ( 0,01 % ) | 184 757 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| HANMI SCIENCE CO., LTD. | Director Ejecutivo | 26/03/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
| YUHAN CORPORATION | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 3 |
|---|---|
Yuhan Corp.
Yuhan Corp. Pharmaceuticals: MajorHealth Technology Engages in the manufacture and marketing of pharmaceutical products | Health Technology |
Kyungpook National University
Kyungpook National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hanmi Science Co., Ltd.
Hanmi Science Co., Ltd. Medical DistributorsDistribution Services Operates as a holding company whose subsidiaries engages in pharmaceutical wholesale & manufacturing and medical device production activities | Distribution Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.